OpenAI introduced ChatGPT for Teens with built-in safeguards aimed at reducing exposure to potentially harmful or developmentally inappropriate content for users under 18. The protections address higher-risk areas including self-harm, eating disorders, violence, dangerous activities and explicit sexual or graphic…
Mental Health
Access to mental healthcare remains out of reach for millions of Americans, with some states facing more severe shortages of mental health professionals than others, new federal data shows. The Health Resources and Services Administration’s Bureau of Health Workforce published…
Just under half of full-time U.S. physicians report burnout at some point and one-fifth report depression, according to a Medscape report published Aug. 3. The report is based on survey insights from 5,159 physicians in 29 specialties collected between Jan.…
As health systems continue to grow through mergers and acquisitions, sustaining physician well-being efforts has become increasingly complex. Leaders at Philadelphia-based Jefferson Health recently shared how the system has integrated clinician well-being into operations, leadership and organizational culture, the American…
The FDA approved Simtriyo (centanafadine), making it the first and only approved norepinephrine, dopamine, serotonin reuptake inhibitor (NDSRI) for the treatment of attention-deficit hyperactivity disorder (ADHD) in adults and pediatric patients aged 6 years and older weighing at least 20…
Advertisement
Nearly 1 in 5 adolescents and young adults in the U.S. — an estimated 8.2 million people — used an AI chatbot for mental health advice in 2025, according to a study published June 1 in JAMA Pediatrics. The findings…
As more teens and young adults seek alternatives or complements to prescription attention-deficit/hyperactivity disorder medications, many are turning to supplements promoted on social media. The trend is fueling sales of products marketed for focus, sleep and mental wellness, even as…
Emergency departments carry the highest suicide-related risk of any non-acute care setting, according to a new analysis from ECRI and the Institute for Safe Medication Practices’ Patient Safety Organization. The analysis draws on 406 incident reports submitted by PSO members…
Eli Lilly and Co. has agreed to acquire AtaiBeckley, a clinical-stage biopharmaceutical company developing innovative therapeutics for mental health conditions, to advance the drugmaker’s push into psychedelic-based research. The acquisition comes as the federal government has pursued actions to advance…
Patient acuity is rising. Approximately 21.2 million adults have a co-occurring mental illness and substance use disorder, according to the Substance Abuse and Mental Health Services Administration’s “2024 National Survey on Drug Use and Health.” As whole-person care continues to…